ABSIPartnership•globenewswire•
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
Sentiment:Positive (70)
Summary
(NASDAQ:ABSI) Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 11, 2025 by globenewswire